Aim
The aim of this pilot is to determine the feasibility and acceptability of the West Moreton (WM) Heart Failure Service virtual model for medication titration for heart failure patients. This pilot is facilitated by the heart failure Nurse Practitioner and Cardiology specialist. The clinical team uses virtual technology to improve access to patients for the pharmacological management of heart failure patients. The program is providing positive outcomes for patients, staff and the organisation and WM is in the process of exploring the possibilities of an external economic evaluation to be conducted to inform if this model should be sustained as part of the long-term service delivery model.
The objective of this new virtual service will be to deliver effective and safe management and monitoring of medications by a Nurse Practitioner via remote patient monitoring and video conferencing.
The aim of the virtual pilot is to:
- improve patient outcomes and experiences for patients
- reduce travel time for staff and patients
- increase patient accessibility to nurse practitioners
- meet statewide clinical guidelines regarding six-month titration review periods
- understand the perspectives and experiences of patients receiving virtual HF care, including key challenges, barriers to completion of the program
- to describe the challenges to delivering and receiving key components of cardiac disease management by a virtual model of care
- to make recommendations for the integration of virtual health into existing Cardiac Chronic Disease Management programs to enable future scalability
- understanding the perspectives and experiences of staff delivering the virtual program including key challenges, barriers to success/completion and key learnings
- identify areas for service improvement
- assess the feasibility and acceptance as a model for integration of virtual health into existing Cardiac Chronic Disease Management programs to enable future scalability.
Outcomes
- improving access to care for those in West Moreton HHS, that have traditionally had barriers to engaging with clinical teams, i.e. rural, remote or working
- efficiency to deliver care and improved consistency of care (4.4 assessments per month versus 1.1 per month)
- shorter time to titrate: average time to titration around seven weeks, with increased activity in first month post discharge
- average length of time on the system 11 weeks
- patient experience measures: Net Promoter Score of 80 per cent promoter for patient experience in the system.
Background
During the COVID-19 pandemic the need arose to monitor some patients (who traditionally had barriers accessing the service) remotely, specifically on the timely medication tritation in their own home.
